• Molecular NameBenzylpenicilloyl Polylysine
  • SynonymNA
  • Weight465.571
  • Drugbank_IDDB00895
  • ACS_NO2642-55-9
  • Show 3D model
  • LogP (experiment)-0.8
  • LogP (predicted, AB/LogP v2.0)-0.32
  • pkaN/A
  • LogD (pH=7, predicted)-2.7
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.27
  • LogSw (predicted, AB/LogsW2.0)11.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors5
  • No.of HBond Acceptors9
  • No.of Rotatable Bonds12
  • TPSA170.13
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include urticaria, generalized pruritus, local swelling, generalized flushing, anaphylaxis, bronchospasm, fainting and maculopapular eruption.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A